REGENTS OF THE UNIVERSITY OF CALIFORNIA 13D/13G Filings for RAPT Therapeutics, Inc. (RAPT)

REGENTS OF THE UNIVERSITY OF CALIFORNIA 13D and 13G filings for RAPT Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-02-01
3:30 pm
Sale
2020-12-3113GRAPT Therapeutics, Inc.
RAPT
REGENTS OF THE UNIVERSITY OF CALIFORNIA1,122,237
4.489%
-220,000decrease
(-16.39%)
Filing
2020-02-24
3:37 pm
Purchase
2019-12-3113GRAPT Therapeutics, Inc.
RAPT
REGENTS OF THE UNIVERSITY OF CALIFORNIA1,342,237
1.000%
1,342,237increase
(New Position)
Filing